Carole Ho, Chief Medical Officer at Denali Therapeutics Inc. (DNLI), sold 12,286 shares at $48.91 ($601K) on 2021-08-23, disclosed to the SEC on 2021-08-25.
Seasonal sale ($601k) by Chief Medical Officer — this insider has traded DNLI in August in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $48.91 | 6,143 | $300K | 50.0% |
| 2 | $48.91 | 6,143 | $300K | 50.0% |
| Total | $48.91 avg | 12,286 | $601K | 100% |
| Filing → |
| DNLI | SELL | 2024-08-22 | $1.1M | — | Filing → |
| DNLI | SELL | 2024-08-15 | $107K | — | Filing → |
| DNLI | SELL | 2024-02-15 | $73K | — | Filing → |